Penumbra, Inc Deferred Revenue Recognized
Penumbra, Inc (PEN) reported Deferred Revenue Recognized of $6.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-02-18
- Penumbra, Inc contract with customer, liability, revenue recognized for the quarter ending 2024-09-30 was $3.10M, a 3000.00% increase year-over-year.
- Penumbra, Inc contract with customer, liability, revenue recognized for the quarter ending 2024-06-30 was $3.60M, a 800.00% increase year-over-year.
- Penumbra, Inc contract with customer, liability, revenue recognized for the quarter ending 2023-09-30 was $100.00K.
- Penumbra, Inc contract with customer, liability, revenue recognized for the quarter ending 2023-06-30 was $400.00K.
- Penumbra, Inc contract with customer, liability, revenue recognized for fiscal 2024 was $6.00M, a 160.87% increase from fiscal 2023.
- Penumbra, Inc contract with customer, liability, revenue recognized for fiscal 2023 was $2.30M, a 59.65% decline from fiscal 2022.
- Penumbra, Inc contract with customer, liability, revenue recognized for fiscal 2022 was $5.70M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2024-12-31 | $6.00M 10-K · filed 2025-02-18 | |||
| 2024-09-30 | $3.10M 10-Q · filed 2024-10-30 | $6.00M 10-Q · filed 2024-10-30 | ||
| 2024-06-30 | $3.60M 10-Q · filed 2024-07-30 | $2.80M 10-Q · filed 2024-07-30 | ||
| 2023-12-31 | $2.30M 10-K · filed 2024-02-22 | |||
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | $400.00K 10-Q · filed 2023-08-01 | $900.00K 10-Q · filed 2023-08-01 | ||
| 2023-03-31 | $500.00K 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $5.70M 10-K · filed 2023-02-23 | |||
| 2022-03-31 | $4.70M 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |